New research shows anti-wrinkle cream chemical works

(Medical Xpress)—University of Reading researchers have found that a chemical used in some anti-wrinkle creams can nearly double the amount of the protein collagen needed to give skin its elasticity.

Due to competition in the cosmetic industry, evidence of the effectiveness of cosmetics is hard to find. The research team measured the effectiveness of a peptide called MatrixylTM on , a protein which repairs . They found that MatrixylTM can almost double the amount of collagen that the cells in our body produce, provided the concentration is high enough.

Professor Ian Hamley, from the University of Reading's Department of Chemistry, said: "Studies like this are very important for the consumer as cosmetic companies rarely publish their work so rivals can't copy their products. Our research, supported by a University studentship with some additional funding by the Engineering and Physical Sciences Research Council (EPSRC), shows that products with MatrixylTM will have skin-care benefits."

Collagen is the most abundant protein in mammals and constitutes a significant proportion of our connective tissue. It is thought that peptide-based treatments that stimulate the formation of collagen could be made to treat wounds and enhance , as well as be used for cosmetic applications.

"Collagen-based materials have immense potential in tissue engineering," continued Professor Hamley. "BBSRC has recently funded the team to investigate wound healing in battlefield applications, as part of a collaboration with the Defence Science and Technology Laboratory, part of the Ministry of Defence."

Research partner Dr Che Connon, Reader in Tissue Engineering and Cell Therapy at the University of Reading, is using collagen based materials in the development of and .

In 2011 Professor Hamley received a prestigious Royal Society Wolfson Research Merit Award as part of a scheme to keep Britain's top research scientists in the UK. His previous research has provided new insights into potential treatments for Alzheimer's disease, a degenerative and incurable form of dementia that afflicts millions of people worldwide.

"Collagen Stimulating Effect of Peptide Amphiphile C16-KTTKS on Human Fibroblasts" was published (with page numbers) on the Molecular Pharmaceutics website on Monday 4 March.

add to favorites email to friend print save as pdf

Related Stories

Key to tissue growth may be in anti-wrinkle cream

Nov 01, 2010

The first study to investigate the chemical structure of an advanced class of anti-wrinkle cream has shown that it could be used to promote wound healing and regenerative medicine.

New method to grow synthetic collagen unveiled

Sep 08, 2011

In a significant advance for cosmetic and reconstructive medicine, scientists at Rice University have unveiled a new method for making synthetic collagen. The new material, which forms from a liquid in as ...

Synthetic collagen from maize has human properties

Jun 24, 2011

Synthetic collagen has a wide range of applications in reconstructive and cosmetic surgery and in the food industry. For proper function in animals a certain number of prolines within the protein need to be hydroxylated. ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

tekram
not rated yet Mar 06, 2013
A particular system, currently in widespread commercial use, is the peptide amphiphile (PA) C16–KTTKS with the trade name (registered to Sederma SA, France) of Matrixyl.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.